Market growth is primarily driven by the rising incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of …
View Press-ReleaseUS Anticoagulation Therapy Market worth USD 27.83 Billion : Expand at a Healthy Growth Rate in the Coming Years
According to the new market research report ” US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type …
View Press-ReleaseUS Anticoagulation Therapy Market worth USD 27.83 Billion : Growth in the Geriatric Population
The market is segmented into products (anticoagulation drugs and PT/INR testing devices) and anticoagulation clinics. The growth in the anticoagulation drugs market is primarily driven …
View Press-ReleaseUS Anticoagulation Therapy Market To Reach USD 27.83 Billion by 2022 – Expansion in Emerging Economies
The market is segmented into products (anticoagulation drugs and PT/INR testing devices) and anticoagulation clinics. The growth in the anticoagulation drugs market is primarily driven …
View Press-ReleaseUS Anticoagulation Therapy Market : Technological advancements in the field of Anticoagulation Therapy
The US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5%. The market is …
View Press-ReleaseUS Anticoagulation Therapy Market : Growing Number of Patients Requiring Lifelong Anticoagulation Therapy
High cost of NOACs and requirement of significant investments in the development of anticoagulation drugs are the major factors restraining the growth of this market. …
View Press-ReleaseUS anticoagulation therapy market to Reach $27.83 Billion With High Growth in anticoagulation therapy
According to the new market research report by MarketsandMarkets, The US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in …
View Press-Release